56 related articles for article (PubMed ID: 12771253)
1. Oculoleptomeningeal amyloidosis in a large kindred with a new transthyretin variant Tyr69His.
Blevins G; Macaulay R; Harder S; Fladeland D; Yamashita T; Yazaki M; Hamidi Asl K; Benson MD; Donat JR
Neurology; 2003 May; 60(10):1625-30. PubMed ID: 12771253
[TBL] [Abstract][Full Text] [Related]
2. Hereditary renal amyloidosis with a variant lysozyme p.Trp82Arg in a Chinese family: case report and literature review.
Li Z; Xu H; Liu D; Li D; Liu G; Wang SX
BMC Nephrol; 2019 Aug; 20(1):310. PubMed ID: 31395023
[TBL] [Abstract][Full Text] [Related]
3. Leptomeningeal Disease Secondary to Thr60Ala Transthyretin Amyloidosis: Case Report and Review of the Literature.
Carberry N; Yu S; Fayerman RN; Dugue R; Miller M; Tanji K; Goyal T; Canoll P; Brannagan TH
Neurohospitalist; 2023 Jan; 13(1):90-95. PubMed ID: 36531853
[TBL] [Abstract][Full Text] [Related]
4. Hereditary Lysozyme Amyloidosis Variant p.Leu102Ser Associates with Unique Phenotype.
Nasr SH; Dasari S; Mills JR; Theis JD; Zimmermann MT; Fonseca R; Vrana JA; Lester SJ; McLaughlin BM; Gillespie R; Highsmith WE; Lee JJ; Dispenzieri A; Kurtin PJ
J Am Soc Nephrol; 2017 Feb; 28(2):431-438. PubMed ID: 28049649
[TBL] [Abstract][Full Text] [Related]
5. Bullous Amyloidosis as a cutaneous feature of Familial Lysozyme Amyloidosis.
Islam R; Abbott L; Potter A; Thomas C
Australas J Dermatol; 2024 May; 65(3):e87-e89. PubMed ID: 38504439
[No Abstract] [Full Text] [Related]
6. A different amyloid formation mechanism: de novo oculoleptomeningeal amyloid deposits after liver transplantation.
Ando Y; Terazaki H; Nakamura M; Ando E; Haraoka K; Yamashita T; Ueda M; Okabe H; Sasaki Y; Tanihara H; Uchino M; Inomata Y
Transplantation; 2004 Feb; 77(3):345-9. PubMed ID: 14966406
[TBL] [Abstract][Full Text] [Related]
7. D18G transthyretin is monomeric, aggregation prone, and not detectable in plasma and cerebrospinal fluid: a prescription for central nervous system amyloidosis?
Hammarström P; Sekijima Y; White JT; Wiseman RL; Lim A; Costello CE; Altland K; Garzuly F; Budka H; Kelly JW
Biochemistry; 2003 Jun; 42(22):6656-63. PubMed ID: 12779320
[TBL] [Abstract][Full Text] [Related]
8. Editorial: Updating amyloid neuropathy knowledge: from diagnosis to treatment.
Conceição I
Front Neurol; 2023; 14():1219317. PubMed ID: 37441612
[No Abstract] [Full Text] [Related]
9. Bilateral Progressive Optic Neuropathy in a Patient with Familial Amyloid Polyneuropathy: Amyloid Deposits in the Optic Nerve Head?
Vela JI; Perich S; Bulnes V; Loscos I; Baradad M
Neuroophthalmology; 2023; 47(3):164-170. PubMed ID: 37398503
[TBL] [Abstract][Full Text] [Related]
10. The Transthyretin/Oleuropein Aglycone Complex: A New Tool against TTR Amyloidosis.
Bemporad F; Leri M; Ramazzotti M; Stefani M; Bucciantini M
Pharmaceuticals (Basel); 2022 Feb; 15(3):. PubMed ID: 35337074
[TBL] [Abstract][Full Text] [Related]
11. Cerebellar and Cerebral Amyloid Visualized by [
Uneus EI; Wilhelmsson C; Bäckström D; Anan I; Wixner J; Pilebro B; Riklund K; Ögren M; Ögreen M; Axelsson J; Suhr OB; Sundström T
Front Neurol; 2022; 13():816636. PubMed ID: 35317351
[TBL] [Abstract][Full Text] [Related]
12. The Amyloid-Tau-Neuroinflammation Axis in the Context of Cerebral Amyloid Angiopathy.
Cisternas P; Taylor X; Lasagna-Reeves CA
Int J Mol Sci; 2019 Dec; 20(24):. PubMed ID: 31847365
[TBL] [Abstract][Full Text] [Related]
13. Impact of Genetic Testing in Transthyretin (ATTR) Cardiac Amyloidosis.
Gopal DM; Ruberg FL; Siddiqi OK
Curr Heart Fail Rep; 2019 Oct; 16(5):180-188. PubMed ID: 31520266
[TBL] [Abstract][Full Text] [Related]
14. New insights into the clinical evaluation of hereditary transthyretin amyloidosis patients: a single center's experience.
Suhr OB; Gustavsson S; Heldestad V; Hörnsten R; Lindqvist P; Nordh E; Wiklund U
Degener Neurol Neuromuscul Dis; 2012; 2():93-106. PubMed ID: 30890882
[TBL] [Abstract][Full Text] [Related]
15. The identification of a transthyretin variant p.D38G in a Chinese family with early-onset leptomeningeal amyloidosis.
Fan K; Zhu H; Xu H; Mao P; Yuan L; Deng H
J Neurol; 2019 Jan; 266(1):232-241. PubMed ID: 30470998
[TBL] [Abstract][Full Text] [Related]
16. Hearing and dementia.
Hardy CJ; Marshall CR; Golden HL; Clark CN; Mummery CJ; Griffiths TD; Bamiou DE; Warren JD
J Neurol; 2016 Nov; 263(11):2339-2354. PubMed ID: 27372450
[TBL] [Abstract][Full Text] [Related]
17. Current and future treatment of amyloid diseases.
Ankarcrona M; Winblad B; Monteiro C; Fearns C; Powers ET; Johansson J; Westermark GT; Presto J; Ericzon BG; Kelly JW
J Intern Med; 2016 Aug; 280(2):177-202. PubMed ID: 27165517
[TBL] [Abstract][Full Text] [Related]
18. Neuropathologic analysis of Tyr69His TTR variant meningovascular amyloidosis with dementia.
Ziskin JL; Greicius MD; Zhu W; Okumu AN; Adams CM; Plowey ED
Acta Neuropathol Commun; 2015 Jul; 3():43. PubMed ID: 26156087
[TBL] [Abstract][Full Text] [Related]
19. Oculoleptomeningeal Amyloidosis associated with transthyretin Leu12Pro in an African patient.
McColgan P; Viegas S; Gandhi S; Bull K; Tudor R; Sheikh F; Pinney J; Fontana M; Rowczenio D; Gillmore JD; Gilbertson JA; Whelan CJ; Shah S; Jaunmuktane Z; Holton JL; Schott JM; Werring DJ; Hawkins PN; Reilly MM
J Neurol; 2015 Jan; 262(1):228-34. PubMed ID: 25488473
[TBL] [Abstract][Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
